annual accounts payable:
$2.94B-$743.00M(-20.15%)Summary
- As of today (September 17, 2025), ABBV annual accounts payable is $2.94 billion, with the most recent change of -$743.00 million (-20.15%) on December 31, 2024.
- During the last 3 years, ABBV annual accounts payable has risen by +$63.00 million (+2.19%).
- ABBV annual accounts payable is now -20.15% below its all-time high of $3.69 billion, reached on December 31, 2023.
Performance
ABBV Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$31.83B+$873.00M(+2.82%)Summary
- As of today (September 17, 2025), ABBV quarterly accounts payable is $31.83 billion, with the most recent change of +$873.00 million (+2.82%) on June 30, 2025.
- Over the past year, ABBV quarterly accounts payable has increased by +$2.54 billion (+8.66%).
- ABBV quarterly accounts payable is now -0.24% below its all-time high of $31.91 billion, reached on December 31, 2024.
Performance
ABBV quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ABBV Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | +8.7% |
| 3 y3 years | +2.2% | +41.6% |
| 5 y5 years | +102.8% | +65.5% |
ABBV Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +2.2% | -0.2% | +984.9% |
| 5 y | 5-year | -20.1% | +102.8% | -0.2% | +1004.5% |
| alltime | all time | -20.1% | +725.4% | -0.2% | +9342.4% |
ABBV Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $31.83B(+2.8%) |
| Mar 2025 | - | $30.96B(-3.0%) |
| Dec 2024 | $2.94B(-20.1%) | $31.91B(+5.0%) |
| Sep 2024 | - | $30.40B(+3.8%) |
| Jun 2024 | - | $29.30B(-6.3%) |
| Mar 2024 | - | $31.26B(+2.4%) |
| Dec 2023 | $3.69B(+25.7%) | $30.52B(+3.2%) |
| Sep 2023 | - | $29.57B(+9.9%) |
| Jun 2023 | - | $26.91B(+9.1%) |
| Mar 2023 | - | $24.65B(+740.3%) |
| Dec 2022 | $2.93B(+1.8%) | $2.93B(-87.5%) |
| Sep 2022 | - | $23.39B(+4.0%) |
| Jun 2022 | - | $22.48B(-0.2%) |
| Mar 2022 | - | $22.53B(+681.9%) |
| Dec 2021 | $2.88B(+26.6%) | $2.88B(-86.8%) |
| Sep 2021 | - | $21.83B(+5.5%) |
| Jun 2021 | - | $20.70B(+1.0%) |
| Mar 2021 | - | $20.49B(+3.3%) |
| Dec 2020 | $2.28B(+56.7%) | $19.84B(+2.7%) |
| Sep 2020 | - | $19.33B(+0.5%) |
| Jun 2020 | - | $19.24B(+51.5%) |
| Mar 2020 | - | $12.70B(+8.8%) |
| Dec 2019 | $1.45B(-6.1%) | $11.66B(-3.0%) |
| Sep 2019 | - | $12.03B(+8.0%) |
| Jun 2019 | - | $11.14B(-4.5%) |
| Mar 2019 | - | $11.67B(-2.0%) |
| Dec 2018 | $1.55B | $11.90B(+5.0%) |
| Sep 2018 | - | $11.34B(+6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $10.65B(+1.0%) |
| Mar 2018 | - | $10.54B(+4.7%) |
| Dec 2017 | $1.47B(+4.8%) | $10.07B(+13.0%) |
| Sep 2017 | - | $8.91B(+2.3%) |
| Jun 2017 | - | $8.71B(+4.1%) |
| Mar 2017 | - | $8.36B(-10.5%) |
| Dec 2016 | $1.41B(-11.9%) | $9.34B(+3.2%) |
| Sep 2016 | - | $9.05B(+4.0%) |
| Jun 2016 | - | $8.70B(+7.0%) |
| Mar 2016 | - | $8.13B(-3.7%) |
| Dec 2015 | $1.60B(+81.3%) | $8.44B(+5.2%) |
| Sep 2015 | - | $8.03B(+11.2%) |
| Jun 2015 | - | $7.22B(+12.4%) |
| Mar 2015 | - | $6.43B(-6.7%) |
| Dec 2014 | $881.00M(-5.6%) | $6.89B(+13.5%) |
| Sep 2014 | - | $6.07B(+1.1%) |
| Jun 2014 | - | $6.01B(-1.9%) |
| Mar 2014 | - | $6.13B(-3.9%) |
| Dec 2013 | $933.00M(+67.8%) | $6.38B(+0.3%) |
| Sep 2013 | - | $6.36B(+0.4%) |
| Jun 2013 | - | $6.33B(+0.4%) |
| Mar 2013 | - | $6.31B(+1034.5%) |
| Dec 2012 | $556.00M(+33.3%) | $556.00M(+31.2%) |
| Sep 2012 | - | $423.91M(+25.7%) |
| Jun 2012 | - | $337.12M(-29.2%) |
| Mar 2012 | - | $476.13M(+14.2%) |
| Dec 2011 | $417.03M(+16.9%) | $417.03M |
| Dec 2010 | $356.78M | - |
FAQ
- What is AbbVie Inc. annual accounts payable?
- What is the all time high annual accounts payable for AbbVie Inc.?
- What is AbbVie Inc. annual accounts payable year-on-year change?
- What is AbbVie Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for AbbVie Inc.?
- What is AbbVie Inc. quarterly accounts payable year-on-year change?
What is AbbVie Inc. annual accounts payable?
The current annual accounts payable of ABBV is $2.94B
What is the all time high annual accounts payable for AbbVie Inc.?
AbbVie Inc. all-time high annual accounts payable is $3.69B
What is AbbVie Inc. annual accounts payable year-on-year change?
Over the past year, ABBV annual accounts payable has changed by -$743.00M (-20.15%)
What is AbbVie Inc. quarterly accounts payable?
The current quarterly accounts payable of ABBV is $31.83B
What is the all time high quarterly accounts payable for AbbVie Inc.?
AbbVie Inc. all-time high quarterly accounts payable is $31.91B
What is AbbVie Inc. quarterly accounts payable year-on-year change?
Over the past year, ABBV quarterly accounts payable has changed by +$2.54B (+8.66%)